>
Maravai LifeSciences Holdings Inc logo

MRVI - Maravai LifeSciences Holdings Inc Share Price

$42.78 1.5  3.6%

Last Trade - 28/07/21

Sector
Healthcare
Size
Large Cap
Market Cap £11.94bn
Enterprise Value £12.25bn
Revenue £285.7m
Position in Universe 702nd / 7000
Bullish
Bearish
Unlock MRVI Revenue
Momentum
Relative Strength (%)
1m -6.16%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -9.81%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 123.8 143.1 284.1 716.5 732.7 +51.5%
-52.2 -2.85
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2021, MaravaiLifesciences Holdings Inc revenues totaled $148.2M. Netincome totaled to $23.2M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MRVI Revenue Unlock MRVI Revenue

Net Income

MRVI Net Income Unlock MRVI Revenue

Normalised EPS

MRVI Normalised EPS Unlock MRVI Revenue

PE Ratio Range

MRVI PE Ratio Range Unlock MRVI Revenue

Dividend Yield Range

MRVI Dividend Yield Range Unlock MRVI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MRVI EPS Forecasts Unlock MRVI Revenue
Profile Summary

Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.

Directors
Last Annual December 31st, 2020
Last Interim March 31st, 2021
No. of Shareholders: 3
No. of Employees: 460
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 400,967,711
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MRVI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MRVI
Upcoming Events for MRVI
Tuesday 10th August, 2021
Q2 2021 Maravai LifeSciences Holdings Inc Earnings Release
Tuesday 10th August, 2021
Q2 2021 Maravai LifeSciences Holdings Inc Earnings Call
Frequently Asked Questions for Maravai LifeSciences Holdings Inc
What is the Maravai LifeSciences Holdings Inc share price?

As of 28/07/21, shares in Maravai LifeSciences Holdings Inc are trading at $42.78, giving the company a market capitalisation of £11.94bn. This share price information is delayed by 15 minutes.

How has the Maravai LifeSciences Holdings Inc share price performed this year?

Shares in Maravai LifeSciences Holdings Inc are currently trading at $42.78 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Maravai LifeSciences Holdings Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Maravai LifeSciences Holdings Inc?

There are no analysts currently covering Maravai LifeSciences Holdings Inc.

When will Maravai LifeSciences Holdings Inc next release its financial results?

Maravai LifeSciences Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Maravai LifeSciences Holdings Inc dividend yield?

Maravai LifeSciences Holdings Inc does not currently pay a dividend.

Does Maravai LifeSciences Holdings Inc pay a dividend?

Maravai LifeSciences Holdings Inc does not currently pay a dividend.

When does Maravai LifeSciences Holdings Inc next pay dividends?

Maravai LifeSciences Holdings Inc does not currently pay a dividend.

How do I buy Maravai LifeSciences Holdings Inc shares?

To buy shares in Maravai LifeSciences Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Maravai LifeSciences Holdings Inc?

Shares in Maravai LifeSciences Holdings Inc are currently trading at $42.78, giving the company a market capitalisation of £11.94bn.

Where are Maravai LifeSciences Holdings Inc shares listed? Where are Maravai LifeSciences Holdings Inc shares listed?

Here are the trading details for Maravai LifeSciences Holdings Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: MRVI
What kind of share is Maravai LifeSciences Holdings Inc?

Based on an overall assessment of its quality, value and momentum, Maravai LifeSciences Holdings Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Maravai LifeSciences Holdings Inc share price forecast 2021?

Shares in Maravai LifeSciences Holdings Inc are currently priced at $42.78. At that level they are trading at 19.44% discount to the analyst consensus target price of 0.00.

Analysts covering Maravai LifeSciences Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of 1.156 for the next financial year.

How can I tell whether the Maravai LifeSciences Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Maravai LifeSciences Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 15.43%. At the current price of $42.78, shares in Maravai LifeSciences Holdings Inc are trading at 17.99% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Maravai LifeSciences Holdings Inc PE Ratio?

The Maravai LifeSciences Holdings Inc PE ratio based on its reported earnings over the past 12 months is 61.45. The shares are currently trading at $42.78.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Maravai LifeSciences Holdings Inc?

We were unable to find the directors for Maravai LifeSciences Holdings Inc.

Who are the major shareholders of Maravai LifeSciences Holdings Inc?

Here are the top five shareholders of Maravai LifeSciences Holdings Inc based on the size of their shareholding:

GTCR Golder Rauner, LLC Private Equity
Percentage owned: 24.18% (27.6m shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 8.1% (9.27m shares)
MFS Investment Management Investment Advisor/Hedge Fund
Percentage owned: 4.71% (5.38m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 4.68% (5.36m shares)
Select Equity Group, L.P. Investment Advisor/Hedge Fund
Percentage owned: 4.02% (4.60m shares)
Similar to MRVI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.